Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Filings indexed 1,000 across all filing types
Latest filing 2021-02-04 Capital/Financing Update
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC, dated February 4, 2021. It is a registration statement under the Securities Act of 1933 for the registration of shares of common stock issuable upon exercise of warrants. The document includes a preliminary prospectus with details about the offering, risk factors, company overview, and development programs. This type of filing is used for initial public offerings or other securities offerings and is not a financial report, earnings release, or management discussion. It is a capital markets filing related to fundraising and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing. Confidence is high given the clear identification as an S-1/A registration statement and prospectus.
2021-02-04 English
Regulatory Filings 2021
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without meaningful content, it cannot be classified as a financial or other specific report type.
2021-02-03 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated January 27, 2021. It is a registration statement under the Securities Act of 1933 for the proposed sale of common stock shares. The text includes details about the offering, company overview, risk factors, and other information typical of an initial or secondary public offering registration statement. This is not an annual report, earnings release, or any other financial report. It is a capital markets filing related to fundraising and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or notice, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2021-01-27 English
SC 13G
Major Shareholding Notification
2021-01-25 English
SABBY 13G TTNP 1.22.21
Major Shareholding Notification
2021-01-22 English
TITAN PHARMACEUTICALS, INC.
Major Shareholding Notification
2021-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.